Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Dwight Egan, Company CEO, will be participating in a fireside chat discussing Company progress on its forthcoming Co-Dx PCR Home™ platform on Thursday, September 21 at 11:00 AM ET. The discussion can be accessed virtually through the Events and Webcasts section of the Co-Diagnostics website.
The Co-Dx PCR Home platform is subject to FDA review and is not available for sale.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-participate-in-gilmartin-group-annual-emerging-growth-showcase-on-sept-21-301934872.html
SOURCE Co-Diagnostics